Efficacy of various disinfectants against SARS coronavirus

Journal of Hospital Infection

Volumn 61, Issue 2, 2005, Pages 107-111

  Rabenau, H F ^a   Kampf, G ^b,c   Cinatl, J ^a   Doerr, H W ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Bode Chemie GmbH   (Germany)

^c UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Disinfectants; prEN 14476; SARS CoV; Virucidal activity

Indexed keywords

2 PROPANOL; ALBUMIN; ALCOHOL; BENZALKONIUM CHLORIDE; DIDECYLDIMETHYLAMMONIUM CHLORIDE; DISINFECTANT AGENT; DISMOZON; DODECYLAMINE; GLUTARALDEHYDE; KOHRSOLIN FF; KORSOLEX; MAGNESIUM DERIVATIVE; METHANOL DERIVATIVE; MIKROBAC FORTE; PROPANOL; STERILLIUM GEL; STERILLIUM RUB; STERILLIUM VIRUGARD; SULFATE; UNCLASSIFIED DRUG;

ARTICLE; DISINFECTION; ERYTHROCYTE; FETAL CALF SERUM; HAND WASHING; HYGIENE; INFECTION CONTROL; INSTRUMENT STERILIZATION; NONHUMAN; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; STERILLIUM; SURFACE PROPERTY; VIRUS INACTIVATION; VIRUS TRANSMISSION;

ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; CERCOPITHECUS AETHIOPS; DETERGENTS; DISINFECTANTS; GELS; HANDWASHING; HUMANS; MICROBIAL SENSITIVITY TESTS; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VERO CELLS;

EID: 24644469592     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2004.12.023     Document Type: Article

References (37)

1. Y. Guan J.S. Peiris B. Zheng et al. Molecular epidemiology of the novel coronavirus that causes severe acute respiratory syndrome Lancet 363 2004 99-104
2. A. Berger C. Drosten H.W. Doerr M. Sturmer W. Preiser Severe acute respiratory syndrome (SARS)-paradigm of an emerging viral infection J Clin Virol 29 2004 13-22
3. F. Fleck SARS virus returns to China as scientists race to find effective vaccine Bull WHO 82 2004 152-153
4. Anonymous Cluster of severe acute respiratory syndrome cases among protected healthcare workers-Toronto, Canada, April 2003 MMWR 52 2003 433-436
5. H.L. Li X.R. Feng L. Dai Q. Yang Epidemiologic investigation of nosocomial infection of SARS in medical staff of hospital Di Yi Jun Yi Da Xue Xue Bao 24 2004 355-358
6. K.Y. Ho K.S. Singh A.G. Habib et al. Mild illness associated with severe acute respiratory syndrome coronavirus infections: Lessons from a prospective seroepidemiologic study of healthcare workers in a teaching hospital in Singapore J Infect Dis 189 2004 642-647
7. S. Manocha K.R. Walley J.A. Russell Severe acute respiratory distress syndrome (SARS): A critical care perspective Crit Care Med 31 2003 2684-2692
8. W.H. Seto D. Tsang R.W.H. Yung et al. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS) Lancet 361 2003 1519-1520
9. G. Kampf Mikrobielle Besiedlung der Hände und ihre epidemiologische Bedeutung In G. Kampf ed. Händehygiene im Gesundheitswesen 2003 Springer Berlin 29-64
10. S.M. Duan X.S. Zhao R.F. Wen et al. Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation Biomed Environ Sci 16 2003 246-255
11. H.F. Rabenau J. Cinatl B. Morgenstern G. Bauer W. Preiser H.W. Doerr Stability and inactivation of SARS coronavirus Med Microbiol Immunol 194 2005 1-6
12. D. Radun M. Niedrig A. Ammon K. Stark SARS: Retrospective cohort study among German guests of the hotel "M", Hong Kong Eurosurveillance 8 2003 228-230
13. Robert Koch-Institut. Empfehlung des Robert Koch-Institutes für die Hygienemaβnahmen und Infektionskontrolle bei Patienten mit Schwerem Akutem Respiratorischem Syndrom (SARS). Berlin: Robert Koch-Institut; 2003.
14. WHO. First data on stability and resistance of SARS coronavirus compiled by members of WHO laboratory network. Geneva: WHO; 2003.
15. DGHM Liste der nach den "Richtlinien für die Prüfung chemischer Desinfektionsmittel" geprüften und von der Deutschen Gesellschaft für Hygiene und Mikrobiologie als wirksam befundenen Desinfektionsverfahren 2002 mhp-Verlag Wiesbaden
16. C. Drosten S. Gunther W. Preiser et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome N Engl J Med 348 2003 1967-1976
17. G. Kärber Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche Arch Exp Path Pharmak 162 1931 480-487
18. C. Spearman The method of 'right or wrong cases' (constant stimuli) without Gauss's formulae Br J Psychol 2 1908 227-242
19. prEN 14476. Chemical disinfectants and antiseptics. Virucidal quantitative suspension test for chemical disinfectants and antiseptics used in human medicine. Test method and requirements (phase 2, step 1). Brussels: Comité Européen de Normalisation; 2002.
20. J. Cinatl B. Morgenstern G. Bauer P. Chandra H. Rabenau H.W. Doerr Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus Lancet 361 2003 2045-2046
21. J. Cinatl B. Morgenstern G. Bauer P. Chandra H. Rabenau H.W. Doerr Treatment of SARS with human interferons Lancet 362 2003 293-294
22. G. Kampf A. Kramer Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs Clin Microbiol Rev 17 2004 863-893
23. V. Groupe C.C. Engle P.E. Gaffney Virucidal activity of representative antiinfective agents against influenza A and vaccinia virus Appl Microbiol 3 1955 333-336
24. G. Kampf M. Rudolf J-C. Labadie S.P. Barrett Spectrum of antimicrobial activity and user acceptability of the hand disinfectant agent Sterillium Gel J Hosp Infect 52 2002 141-147
25. C.H. Cunningham The effect of certain chemical agents on the virus of Newcastle disease of chicken Am J Vet Res 9 1948 195-197
26. M.A. Bucca The effect of various chemical agents on eastern equine encephalomyelitis virus J Bacteriol 71 1956 491-492
27. W.X.V. Bond M.S. Favero N.J. Petersen Inactivation of hepatitis B virus by intermediate to high-level disinfectant chemicals J Clin Microbiol 18 1983 535-538
28. H. Kobayashi M. Tsuzuki K. Koshimizu Susceptibility of hepatitis B virus to disinfectants or heat J Clin Microbiol 20 1984 214-216
29. C. Payan A. Pivert G. Kampf C. Ramon J. Cottin C. Lemarie Assessment of new chemical disinfectants for HBV virucidal activity in a cell culture model J Hosp Infect 56 2004 S58-S63
30. L.S. Martin J.S. Meoougal S.L. Loskoski Disinfection and inactivation of the human T lymphotropic virus type III/lymphadenopathy associated virus J Infect Dis 152 1985 400-403
31. B. Spire F. Barre-Sinoussi L. Montagnier Inactivation of lymphadenopathy associated virus by chemical disinfectants Lancet 2 1984 899-901
32. I. Reiss A. Borkhardt R. Fussle A. Sziegoleit L. Gortner Disinfectant contaminated with Klebsiella oxytoca as a source of sepsis in babies Lancet 356 2000 310-311
33. W.A. Rutala D.J. Weber Reprocessing endoscopes: United States perspective J Hosp Infect 56 2004 S27-S39
34. H. Martiny H. Floss B. Zühlsdorf The importance of cleaning for the overall results of processing endoscopes J Hosp Infect 56 2004 S16-S22
35. P. Heeg Reprocessing endoscopes: National recommendations with a special emphasis on cleaning-the German perspective J Hosp Infect 56 2004 S23-S26
36. J.C. Darbord Importance of cleaning for reprocessing endoscopes and thermolabile sterile medical devices: French use and regulations J Hosp Infect 56 2004 S40-S43
37. G. Kampf D. Grotheer J. Steinmann Efficacy of three ethanol-based hand rubs against feline calicivirus (FCV) J Hosp Infect 2005 [in press]